Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations

Hepatocellular carcinoma (HCC) is the most common primary liver tumor and has been considered a very immunogenic tumor. The treatment with radiofrequency ablation (RFA) has been established as the standard ablative therapy for early HCC, and is currently recognized as the main ablative tool for HCC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: da Costa, Adriano Carneiro, Sodergren, Mikael, Jayant, Kumar, Santa Cruz, Fernando, Spalding, Duncan, Pai, Madhava, Habib, Nagy
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2020
Matèries:
Minireviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7267689/
https://ncbi.nlm.nih.gov/pubmed/32536773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i17.2040
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars